Impressed by PerkinElmer's (PKI +7%) "shock and awe" Q4 results, Jefferies raises its earnings...

|By:, SA News Editor

Impressed by PerkinElmer's (PKI +7%) "shock and awe" Q4 results, Jefferies raises its earnings estimates and price target to $27 from $23. "Our focus remains on PKI's ability to consistently drive OP margin expansion," the firm says. The provider of equipment for genetic screening and drug research forecasts 2012 EPS of $1.98-$2.04 vs. $1.91 consensus.